Large pharmaceutical companies have increasingly taken a "search" rather "research" approach to therapy development. This means that rare diseases have lower visibility and are dependent on research foundations and disease-specific biotechs to drive the discovery and development of therapies. Shepherd Therapeutics aims to be a part of that revolution, one that will find and guide future therapies for rare diseases and help create a more adaptive blueprint for the research and development of disease therapy.

Industry

Health and/or Sciences

Contact

• Contact person: David Hysong
• E-mail: [email protected]
• Project URL: www.ShepherdTherapeutics.com